Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoimmunity | 11 | 2025 | 249 | 1.970 |
Why?
|
| B-Lymphocytes | 12 | 2024 | 565 | 1.560 |
Why?
|
| Autoimmune Diseases | 7 | 2025 | 239 | 1.470 |
Why?
|
| Membrane Proteins | 6 | 2026 | 926 | 1.380 |
Why?
|
| Gain of Function Mutation | 2 | 2026 | 20 | 1.350 |
Why?
|
| Toll-Like Receptors | 8 | 2016 | 434 | 1.290 |
Why?
|
| Endothelial Cells | 2 | 2026 | 215 | 1.190 |
Why?
|
| Lymphocyte Activation | 14 | 2015 | 754 | 1.150 |
Why?
|
| Toll-Like Receptor 9 | 10 | 2016 | 207 | 1.000 |
Why?
|
| Autoantigens | 7 | 2015 | 140 | 1.000 |
Why?
|
| Receptors, Antigen, B-Cell | 7 | 2015 | 60 | 0.900 |
Why?
|
| Ultraviolet Rays | 1 | 2026 | 153 | 0.870 |
Why?
|
| Skin | 2 | 2026 | 436 | 0.750 |
Why?
|
| Nucleic Acids | 3 | 2025 | 67 | 0.740 |
Why?
|
| Fas Ligand Protein | 5 | 2018 | 40 | 0.590 |
Why?
|
| Mice | 28 | 2026 | 11174 | 0.580 |
Why?
|
| Inflammation | 6 | 2025 | 1195 | 0.560 |
Why?
|
| DNA | 6 | 2015 | 853 | 0.550 |
Why?
|
| Animals | 34 | 2026 | 21467 | 0.520 |
Why?
|
| Disease Models, Animal | 7 | 2026 | 2327 | 0.480 |
Why?
|
| RNA | 5 | 2015 | 427 | 0.470 |
Why?
|
| Autoantibodies | 7 | 2015 | 186 | 0.470 |
Why?
|
| Toll-Like Receptor 7 | 4 | 2015 | 104 | 0.390 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2014 | 222 | 0.380 |
Why?
|
| Mice, Knockout | 13 | 2016 | 2168 | 0.340 |
Why?
|
| Endodeoxyribonucleases | 3 | 2016 | 44 | 0.330 |
Why?
|
| DNA-Binding Proteins | 3 | 2024 | 1226 | 0.320 |
Why?
|
| Lung | 2 | 2024 | 969 | 0.310 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2013 | 183 | 0.300 |
Why?
|
| Immunologic Memory | 1 | 2011 | 284 | 0.300 |
Why?
|
| Rheumatoid Factor | 3 | 2015 | 13 | 0.300 |
Why?
|
| Interferon Type I | 2 | 2019 | 198 | 0.300 |
Why?
|
| Epithelium, Corneal | 1 | 2018 | 9 | 0.290 |
Why?
|
| Keratitis | 1 | 2018 | 19 | 0.280 |
Why?
|
| Debridement | 1 | 2018 | 35 | 0.280 |
Why?
|
| Endosomes | 2 | 2016 | 180 | 0.270 |
Why?
|
| Flow Cytometry | 6 | 2016 | 664 | 0.260 |
Why?
|
| Mice, Transgenic | 7 | 2015 | 1291 | 0.240 |
Why?
|
| Mice, Inbred BALB C | 7 | 2016 | 869 | 0.240 |
Why?
|
| Arthritis, Experimental | 1 | 2016 | 30 | 0.230 |
Why?
|
| Lupus Nephritis | 1 | 2016 | 37 | 0.230 |
Why?
|
| Antigen-Antibody Complex | 4 | 2010 | 52 | 0.230 |
Why?
|
| Epitopes | 1 | 2007 | 291 | 0.230 |
Why?
|
| Myeloid Cells | 1 | 2016 | 98 | 0.230 |
Why?
|
| Arthritis | 1 | 2015 | 52 | 0.230 |
Why?
|
| Stromal Cells | 1 | 2016 | 78 | 0.230 |
Why?
|
| Cell Lineage | 1 | 2016 | 282 | 0.220 |
Why?
|
| Capsid Proteins | 1 | 2026 | 107 | 0.220 |
Why?
|
| Membrane Glycoproteins | 5 | 2015 | 667 | 0.210 |
Why?
|
| Transduction, Genetic | 1 | 2026 | 242 | 0.210 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 300 | 0.210 |
Why?
|
| Death, Sudden | 1 | 2024 | 31 | 0.200 |
Why?
|
| Eye | 1 | 2024 | 59 | 0.200 |
Why?
|
| Dendritic Cells | 4 | 2015 | 531 | 0.200 |
Why?
|
| Cell Proliferation | 6 | 2015 | 1044 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 3501 | 0.190 |
Why?
|
| Genetic Vectors | 2 | 2026 | 929 | 0.190 |
Why?
|
| Macular Degeneration | 1 | 2026 | 196 | 0.190 |
Why?
|
| Ligands | 5 | 2015 | 414 | 0.190 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 128 | 0.190 |
Why?
|
| Retinal Ganglion Cells | 1 | 2011 | 34 | 0.170 |
Why?
|
| Humans | 13 | 2026 | 65654 | 0.160 |
Why?
|
| Receptors, IgG | 1 | 2010 | 41 | 0.160 |
Why?
|
| fas Receptor | 3 | 2012 | 56 | 0.160 |
Why?
|
| Glaucoma | 1 | 2011 | 68 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2010 | 213 | 0.160 |
Why?
|
| HMGB1 Protein | 1 | 2010 | 26 | 0.150 |
Why?
|
| Cell Membrane | 2 | 2011 | 506 | 0.150 |
Why?
|
| Dependovirus | 1 | 2026 | 760 | 0.140 |
Why?
|
| Genetic Therapy | 1 | 2026 | 852 | 0.140 |
Why?
|
| Ovalbumin | 3 | 2014 | 108 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 1634 | 0.130 |
Why?
|
| Apoptosis | 3 | 2013 | 1100 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 449 | 0.130 |
Why?
|
| Interleukin-21 Receptor alpha Subunit | 1 | 2015 | 2 | 0.120 |
Why?
|
| Cell Differentiation | 3 | 2015 | 1389 | 0.120 |
Why?
|
| Interleukin-13 | 1 | 2015 | 37 | 0.110 |
Why?
|
| Interleukins | 1 | 2015 | 88 | 0.110 |
Why?
|
| Pulmonary Fibrosis | 1 | 2015 | 81 | 0.110 |
Why?
|
| Membrane Transport Proteins | 2 | 2016 | 135 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 169 | 0.110 |
Why?
|
| Chromatin | 3 | 2010 | 643 | 0.110 |
Why?
|
| Cells, Cultured | 4 | 2015 | 2193 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2004 | 77 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2024 | 209 | 0.100 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2024 | 145 | 0.090 |
Why?
|
| Interleukin-18 | 1 | 2012 | 75 | 0.090 |
Why?
|
| Caspase 8 | 1 | 2012 | 66 | 0.090 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2012 | 84 | 0.090 |
Why?
|
| Signal Transduction | 6 | 2015 | 3164 | 0.090 |
Why?
|
| Terpenes | 2 | 2016 | 28 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 274 | 0.080 |
Why?
|
| Models, Animal | 1 | 2011 | 242 | 0.080 |
Why?
|
| Skin Diseases | 1 | 2011 | 81 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 642 | 0.080 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 23 | 0.080 |
Why?
|
| Exodeoxyribonucleases | 1 | 2019 | 29 | 0.080 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2015 | 54 | 0.080 |
Why?
|
| Interferon-alpha | 2 | 2006 | 101 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 59 | 0.070 |
Why?
|
| Immunosuppressive Agents | 2 | 2016 | 381 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 542 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 169 | 0.070 |
Why?
|
| Interferon-beta | 1 | 2009 | 79 | 0.070 |
Why?
|
| Corneal Neovascularization | 1 | 2018 | 2 | 0.070 |
Why?
|
| Corneal Stroma | 1 | 2018 | 11 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2018 | 37 | 0.070 |
Why?
|
| Mice, Inbred CBA | 2 | 2013 | 80 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2019 | 224 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2018 | 132 | 0.070 |
Why?
|
| Plasmids | 1 | 2018 | 294 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2018 | 611 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2013 | 301 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 372 | 0.060 |
Why?
|
| Transcriptome | 2 | 2015 | 405 | 0.060 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2016 | 12 | 0.060 |
Why?
|
| Models, Immunological | 1 | 2006 | 85 | 0.060 |
Why?
|
| Solubility | 2 | 2011 | 193 | 0.060 |
Why?
|
| Radiation Chimera | 1 | 2016 | 61 | 0.060 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2015 | 6 | 0.060 |
Why?
|
| Splenomegaly | 1 | 2015 | 22 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 625 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 735 | 0.060 |
Why?
|
| Syndecan-1 | 1 | 2015 | 9 | 0.060 |
Why?
|
| Retina | 1 | 2026 | 135 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 514 | 0.050 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 43 | 0.050 |
Why?
|
| Transgenes | 1 | 2026 | 207 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2015 | 103 | 0.050 |
Why?
|
| Capsid | 1 | 2026 | 104 | 0.050 |
Why?
|
| Plasma Cells | 1 | 2015 | 52 | 0.050 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2015 | 98 | 0.050 |
Why?
|
| Immunoglobulin G | 2 | 2007 | 472 | 0.050 |
Why?
|
| Interferons | 1 | 2015 | 74 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2026 | 234 | 0.050 |
Why?
|
| Time Factors | 1 | 2011 | 3777 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 297 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2007 | 744 | 0.050 |
Why?
|
| Genotype | 1 | 2015 | 674 | 0.050 |
Why?
|
| Cell Line | 2 | 2010 | 2030 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2002 | 116 | 0.040 |
Why?
|
| Phenotype | 1 | 2015 | 1235 | 0.040 |
Why?
|
| Cytoprotection | 1 | 2011 | 18 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2011 | 32 | 0.040 |
Why?
|
| Injections | 1 | 2011 | 84 | 0.040 |
Why?
|
| Retinal Degeneration | 1 | 2011 | 28 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2010 | 42 | 0.040 |
Why?
|
| Interleukin-2 | 2 | 2014 | 167 | 0.040 |
Why?
|
| Cytokines | 2 | 2009 | 964 | 0.040 |
Why?
|
| Female | 5 | 2018 | 34310 | 0.040 |
Why?
|
| Cell Communication | 1 | 2010 | 135 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 432 | 0.040 |
Why?
|
| Cell Death | 1 | 2011 | 289 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2014 | 963 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 2 | 2005 | 10 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 604 | 0.030 |
Why?
|
| Microglia | 1 | 2011 | 254 | 0.030 |
Why?
|
| Protein Binding | 1 | 2011 | 1636 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 758 | 0.030 |
Why?
|
| Bleomycin | 1 | 2015 | 35 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2015 | 147 | 0.030 |
Why?
|
| Child | 1 | 2024 | 4634 | 0.030 |
Why?
|
| Diphenylamine | 1 | 2014 | 4 | 0.030 |
Why?
|
| Antigens, Differentiation | 2 | 2005 | 144 | 0.030 |
Why?
|
| BALB 3T3 Cells | 1 | 2013 | 5 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 145 | 0.020 |
Why?
|
| Benzamides | 1 | 2014 | 69 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2004 | 171 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 80 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2005 | 203 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 132 | 0.020 |
Why?
|
| Receptors, Immunologic | 2 | 2005 | 179 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2014 | 101 | 0.020 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2012 | 11 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2012 | 75 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 391 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2013 | 178 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2014 | 576 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2005 | 441 | 0.020 |
Why?
|
| Male | 3 | 2013 | 31297 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2000 | 84 | 0.020 |
Why?
|
| Peritoneum | 1 | 2000 | 31 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2000 | 173 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 426 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2012 | 352 | 0.020 |
Why?
|
| Cell Survival | 1 | 2000 | 588 | 0.020 |
Why?
|
| Tyrosine | 1 | 2007 | 93 | 0.020 |
Why?
|
| Binding Sites | 1 | 2000 | 921 | 0.020 |
Why?
|
| Neutrophils | 1 | 2000 | 396 | 0.020 |
Why?
|
| Hybridomas | 1 | 2005 | 63 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2007 | 435 | 0.010 |
Why?
|
| Ribonucleoproteins | 1 | 2005 | 116 | 0.010 |
Why?
|
| Calcium | 1 | 2007 | 587 | 0.010 |
Why?
|
| Receptors, Complement 3b | 1 | 2002 | 12 | 0.010 |
Why?
|
| Receptors, Complement 3d | 1 | 2002 | 15 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 2002 | 41 | 0.010 |
Why?
|